Covid trial of cholesterol treatment
Scientists at the Hebrew University of Jerusalem successfully trialed TriCor (fenofibrate see previously) on 15 severely ill Covid patients. 14 were weaned off their ventilators within a week. TriCor targets inflammation-producing lipids produced by the coronavirus.
Israeli vaccine Phase 2 trials commence
Israel’s Institute for Biological Research IIBR (see previously) has stated that it has delivered 1,000 doses of its BriLife coronavirus vaccine to Georgia for starting Phase 2 trials. IIBR’s partner, NRx, will lead the trials, expand patient numbers and prepare for Phase 3.
Coronavirus latest
Some 2.3 million Israelis have now had a coronavirus booster. It is 95% effective against infection and available to all Israelis vaccinated over 5 months ago. Serious case numbers have declined and are nearly negligible in those who have been triple-vaccinated. Some 2.5 million children have returned to school.
First 3D printed active tumor
After Researchers at Tel Aviv University have printed an entire active and viable glioblastoma (brain cancer) tumor using a 3D printer. It includes simulated brain tissue and blood vessel-like tubes through which blood cells can flow and treatments can be (and have been) tested.
Coronavirus booster progress
Some 1.2 million Israelis have now had a third coronavirus vaccination and wider rollout is imminent. Maccabi Healthcare Services reported 37 (all non-serious) infections in Israelis over 60 who have been triple-vaccinated, compared to 1,064 (many serious) for those who have had only two doses.
Covid treatment is too cheap
Professor Eli Schwartz of Israel’s Sheba Medical Center was unable to publish the results of his successful double-blind trial of ivermectin on 89 coronavirus patients. Interesting reading.
Trial approved for Alzheimer’s treatment
Israel’s SciSparc to commence a Phase 2a clinical trial of its SCI-110 (formerly THX-110) treatment for patients with Alzheimer's disease (AD) and agitation. The study will be conducted at the Israeli Medical Center for Alzheimer's.
New therapies for mental illness
Israel’s Nextage Therapeutics is developing technology to deliver to the brain tiny quantities of controversial chemicals, to treat depression and other neurological disorders.
How the brain maps 3D space
Scientists from Israel’s Weizmann Institute and the Hebrew University of Jerusalem have unveiled how 3-dimensional space is represented in the brain’s “GPS” system. They mapped out how “grid cells” work in bats and the findings have turned the previous theory “on its head”.
Rejuvenating the immune system
The reason the elderly are vulnerable to Covid, is their immune systems fail to recognize a new virus. Scientists at Israel’s Technion Institute, Sourasky (Ichilov) and Rambam hospitals have demonstrated that removing most of the memory B lymphocytes rejuvenates these immune cells.